Literature DB >> 15486868

The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology.

Ronald L Pisoni1, Brenda W Gillespie, David M Dickinson, Kenneth Chen, Michael H Kutner, Robert A Wolfe.   

Abstract

The Dialysis Outcomes and Practice Patterns Study (DOPPS) is a prospective, observational study designed to elucidate aspects of hemodialysis practice that are associated with the best outcomes for hemodialysis patients. In DOPPS I, 308 hemodialysis units from 7 countries participated, including 145 facilities from the United States (1996-2001), 62 facilities from Japan (1999-2001), and 101 facilities from France, Germany, Italy, Spain, and the United Kingdom (all 1998-2000). DOPPS II (2002-2004) has included 320 hemodialysis units and more than 12,400 hemodialysis patients from the 7 DOPPS I countries as well as Australia, Belgium, Canada, New Zealand, and Sweden. Dialysis units are chosen via a stratified random selection procedure to provide proportional sampling by region and type of facility within each country. In DOPPS I and II, longitudinal data have been collected from both a prevalent (cross-sectional) patient sample and an incident patient sample. Data have also been collected on numerous facility practice patterns. Most DOPPS analyses incorporate both facility- and patient-level data in regression-based analyses to investigate predictors of survival, hospitalization, quality of life, vascular access type, and other outcomes. DOPPS longitudinal data also help identify trends in subject characteristics, practice indicators, medication use, and outcomes. The DOPPS remains a unique source of data on hemodialysis patients and facilities. It continues to refine its methods of data collection and analysis with the goal of improving hemodialysis practice and end-stage renal disease patient lives worldwide.

Entities:  

Mesh:

Year:  2004        PMID: 15486868     DOI: 10.1053/j.ajkd.2004.08.005

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  126 in total

1.  Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.

Authors:  David A Goodkin; Douglas S Fuller; Bruce M Robinson; Christian Combe; Richard Fluck; David Mendelssohn; Tadao Akizawa; Ronald L Pisoni; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

Review 2.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

Review 3.  Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis.

Authors:  Moshe Vardi; Robert W Yeh; Charles A Herzog; Wolfgang C Winkelmayer; Soko Setoguchi; David M Charytan
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 8.237

4.  Changes in Quality of Life in Older Hemodialysis Patients: A Cohort Study on Dialysis Outcomes and Practice Patterns.

Authors:  Ayumi Ishiwatari; Shungo Yamamoto; Shingo Fukuma; Takeshi Hasegawa; Sachiko Wakai; Masaomi Nangaku
Journal:  Am J Nephrol       Date:  2020-07-31       Impact factor: 3.754

5.  Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.

Authors:  Hirotaka Komaba; Mia Wang; Masatomo Taniguchi; Suguru Yamamoto; Takanobu Nomura; Douglas E Schaubel; Abigail R Smith; Jarcy Zee; Angelo Karaboyas; Brian Bieber; Masafumi Fukagawa; Francesca Tentori
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-19       Impact factor: 8.237

6.  Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study.

Authors:  Brian Bieber; Jiaqi Qian; Shuchi Anand; Yucheng Yan; Nan Chen; Mia Wang; Mei Wang; Li Zuo; Fan Fan Hou; Ronald L Pisoni; Bruce M Robinson; Sylvia P B Ramirez
Journal:  Nephrol Dial Transplant       Date:  2013-12-08       Impact factor: 5.992

7.  Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Hugh C Rayner; Lindsay Zepel; Douglas S Fuller; Hal Morgenstern; Angelo Karaboyas; Bruce F Culleton; Donna L Mapes; Antonio A Lopes; Brenda W Gillespie; Takeshi Hasegawa; Rajiv Saran; Francesca Tentori; Manfred Hecking; Ronald L Pisoni; Bruce M Robinson
Journal:  Am J Kidney Dis       Date:  2014-02-14       Impact factor: 8.860

Review 8.  Quality indicators of vascular access procedures for hemodialysis.

Authors:  Branko Fila
Journal:  Int Urol Nephrol       Date:  2020-08-31       Impact factor: 2.370

9.  International variation in dialysis discontinuation in patients with advanced kidney disease.

Authors:  Sarbjit V Jassal; Maria Larkina; Kitty J Jager; Fliss E M Murtagh; Ann M O'Hare; Norio Hanafusa; Hal Morgenstern; Friedrich K Port; Keith McCullough; Ronald Pisoni; Francesca Tentori; Rachel Perlman; Richard D Swartz
Journal:  CMAJ       Date:  2020-08-31       Impact factor: 8.262

10.  Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing.

Authors:  Angelo Karaboyas; Jarcy Zee; Hal Morgenstern; Jacqueline G Nolen; Raymond Hakim; Kamyar Kalantar-Zadeh; Philip Zager; Ronald L Pisoni; Friedrich K Port; Bruce M Robinson
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.